Areas of Focus
- Immune Surveillance and Tumors
- Gene Modification and Cell Engineering
Work Experience
- 2005-2009 - University of Pennsylvania - Postdoctoral Research
- 2009-present - Nanjing University - PI, Professor at Model Animal Research Institute
Academic Background & Achievements
- 1998 - Bachelor's Degree: Nanjing University, Biochemistry
- 2005 - Ph.D.: Boston University School of Medicine, Biochemistry
Publications
- Precise somatic genome editing for treatment of inborn errors of immunity, Meng Q, Sun H* and Liu J*, 2023
- Enhancement of prime editing via xrRNA motif-joined pegRNA, Zhang G†, Liu Y†, Huang S†, Qu S, Cheng D, Yao Y, Ji Q, Wang X*, Huang X* and Liu J*, 2022
- Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors, Wang Y†, Zhang G†, Meng Q†, Huang S, Guo P, Leng Q, Liu G*, Huang X* and Liu J*, 2022
- CRISPR/Cas12a-assisted rapid identification of beer spoilage bacteria, Meng Q†, Yang H†, Zhang G, Ma P, Liu X, Dang L, Li G, Huang X, Wang X*, Liu J* and Leng Q*, 2021
- A monocyte-orchestrated IFN-I-to-IL-4 cytokine axis instigates pro-tumoral macrophages and thwarts poly(I:C) therapy, Gup P†, Yang L†, Zhang M, Zhang Y, Tong Y, Cao Y and Liu J*, 2021
- Concomitant Type I IFN and M-CSF signaling reprograms monocyte differentiation to drive pro-tumoral arginase production, Tong Y†, Zhou L†, Yang L, Cao Y, Qin FX and Liu J*, 2019